The TOSCA registry revealed that over 90% of HF patients had deficiencies in at least one anabolic hormone, such as testosterone, dehydroepiandrosterone sulfate, insulin-like growth factor-I (IGF-I), or triiodothyronine. The gene discussed is IGF1; the disease is hydrops fetalis.